ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio
August 02, 2022 05:00 ET
|
ResMed Inc.
Acquisition lays foundation to build ResMed’s digital sleep medicine portfolio in Germanysomnio digital health application focused on improving sleep in patients with diagnosed insomnia, filling care...
ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022
July 14, 2022 16:05 ET
|
ResMed Inc.
SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2022 on...
ResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care
June 28, 2022 09:00 ET
|
ResMed Inc.
Blaise is a medtech industry thought leader with over 25 years’ experienceA board member of MedTech Europe since 2020; President of the Snitem, France’s premier medtech associationPromotion effective...
ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions
June 14, 2022 02:05 ET
|
ResMed Inc.
Acquisition creates a global leader in out-of-hospital software solutionsAccelerates ResMed’s SaaS strategy by extending ResMed’s position as a leading U.S. provider of SaaS solutions in...
ResMed Announces Participation in the 43rd Annual Goldman Sachs Global Healthcare Conference
June 07, 2022 09:00 ET
|
ResMed Inc.
SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Goldman Sachs Global...
ResMed Announces Participation in the 42nd Annual William Blair Growth Stock Conference
June 01, 2022 09:00 ET
|
ResMed Inc.
SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the William Blair Growth Stock...
ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference
May 25, 2022 09:00 ET
|
ResMed Inc.
SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bernstein Strategic...
Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study
May 18, 2022 16:05 ET
|
ResMed Inc.
2–3 hours of nightly PAP use shows health benefits at 3 months, 1 year, and 2 yearsHealth benefits significantly increase by use hour/night, up to 7 hours SAN FRANCISCO, May 18, 2022 (GLOBE...
ResMed Announces Leadership Change
May 05, 2022 16:05 ET
|
ResMed Inc.
SAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced that Jim Hollingshead, President, Sleep and Respiratory Care, has informed ResMed that he has accepted a new...
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022
April 28, 2022 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 12%, operating profit up 5%, non-GAAP operating profit up 5% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today...